Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 23, 1998, Pages 13875-13880

  Schimke, Jan ^a   Mathison, John ^a   Morgiewicz, Janice ^a   Ulevitch, Richard J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CELL ACTIVATION; CELL SURFACE; GRAM NEGATIVE BACTERIUM; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEPTIC SHOCK;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; ENDOTOXINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; RABBITS;

EID: 0032506137     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.23.13875     Document Type: Article

References (28)

1. Bone, R. C. (1991) Chest 100, 802-808.
2. Wolff, S. M. & Bennett, J. V. (1974) N. Engl. J. Med. 291, 733-734.
3. Stone, R. (1994) Science 64, 365-367.
4. Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M. & Parillo, J. E. (1991) Chest 99, 169-175.
5. van Deventer, S. J. H., Buller, H. R., ten Cate, J. W., Sturk, A. & Pauw, W. (1988) Lancet 1, 605-609.
6. Ziegler E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H. & Braude, A. I. (1982) N. Engl. J. Med. 307, 1125-1130.
7. Kreger, B. E., Craven, D. E. & McCabe, W. R. (1980) Am. J. Med. 68, 344-355.
8. Hazinski, M. F., Iberti, T. J., MacIntyre, N. R., Parker, M. M., Tribett, D., Prion, S. & Chmel, H. (1993) Am. J. Crit. Care 2, 224-237.
9. Evans, G. F., Snyder, Y. M., Butler, L. D. & Zuckerman, S. H. (1989) Circ. Shock 29, 279-290.
10. Ramadori, G., Van Damme, J., Rieder, H. & Meyer zum Buschendelde, K.-H. (1988) Eur. J. Immunol. 18, 1259-1264.
11. Sgadari, C., Angiolillo, A. L., Cherney, B. W., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N., Gupta, G., et al. (1996) Proc. Natl. Acad. Sci. USA 93, 13791-13796.
12. Baue, A. R. (1995) Shock 4, 39-40.
13. Ulevitch, R. J. & Tobias, P. S. (1995) Annu. Rev. Immunol. 13, 437-457.
14. Haziot, A., Ferrero, E., Lin, X. Y., Stewart, C. L. & Goyert, S. M. (1995) in CD14-Deficient Mice Are Exquisitely Insensitive to the Effects of LPS, eds. Levin, J., Alving, C. R., Munford, R. S. & Redl, H. (Wiley, New York), pp. 349-351.
15. Haziot, A., Ferrero, E., Kontgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L. & Goyert, S. M. (1996) Immunity 4, 407-414.
16. Jack, R. S., Fan, X., Bernheiden, M., Rune, G., Ehlers, M., Weber, A., Kirsch, G., Mentel, R., Furll, B., Freudenberg, M., et al. (1997) Nature (London) 389, 742-745.
17. Grau, G. E. & Maennel, D. N. (1997) Nat. Med. 3, 1193-1195.
18. Deitch, E. A. (1998) Shock 9, 1-11.
19. Wichterman, K. A., Baue, A. E. & Chaudry, I. H. (1980) J. Surg. Res. 29, 189-201.
20. Mathison, J. C., Wolfson, E. & Ulevitch, R. J. (1988) J. Clin. Invest. 81, 1925-1937.
21. DeForge, L. E. & Remick, D. G. (1991) Immunol. Invest. 20, 89-97.
22. Desch, C. E., Kovach, N. L., Present, W., Broyles, C. & Harlan, J. M. (1989) Lymphokine Res. 8, 141-146.
23. Espevik, T. & Nissen-Meyer, J. (1986) J. Immunol. Methods 95, 99-105.
24. Bebbington, C. R. & Hentschel, C. C. G. (1987) in The Use of Vectors Based on Gene Amplification for the Expression of Cloned Genes in Mammalian Cells, ed. Glover, D. (Academic, New York), pp. 163-188.
25. Kravchenko, V. V., Steinemann, S., Kline, L., Feng, L. & Ulevitch, R. J. (1996) Shock 5, 194-201.
26. Mathison, J. C., Virca, G. D., Wolfson, N., Tobias, P. S., Glaser, K. & Ulevitch, R. J. (1990) J. Clin. Invest. 85, 1108-1118.
27. Raij, L., Keane, W. F. & Michael, A. F. (1977) Kidney Int. 12, 91-95.
28. Dellinger, R. P., Opal, S. M., Rotrosen, D., Suffredini, A. D. & Zimmerman, J. L. (1997) Chest 744-753.